AlignClinical
Clinical-grade bioinformatics for regulated environments
What AlignClinical Will Offer
AlignClinical is being built for bioinformatics in regulated environments — pharmaceutical development, clinical trials, and diagnostic laboratories. The pipeline will integrate transcriptomic analysis with clinical metadata to support therapeutic decision-making, while generating documentation aligned with FDA/EMA requirements.
Planned capabilities include treatment response prediction from molecular profiles, patient stratification for clinical trial design, survival analysis integrated with gene expression data, and audit-ready analysis documentation with full reproducibility guarantees.
Whether you’re validating companion diagnostics, stratifying trial cohorts, or building regulatory submissions, AlignClinical will provide the analytical rigor and documentation standards required for clinical-grade work.
Planned Capabilities
Treatment Response Prediction
Molecular profile-based prediction of treatment outcomes using validated biomarker signatures.
Patient Stratification
Identify patient subgroups for clinical trial design using transcriptomic clustering approaches.
Survival Analysis
Integrated survival analysis with gene expression data, including Kaplan-Meier and Cox regression.
Regulatory Documentation
Audit-ready analysis reports with full reproducibility, version control, and validation logs.
Target Audience
- Pharmaceutical companies and CROs running clinical trials with transcriptomic endpoints
- Clinical laboratories developing or validating molecular diagnostic assays
- Translational research groups bridging bench findings to clinical applications
- Regulatory affairs teams requiring compliant bioinformatics documentation
Get Notified
Interested in AlignClinical? Contact us to join the early access list and participate in requirements discussions.